Status:
UNKNOWN
Multicentric Risk Evaluation of Autologous Fat Grafting Procedure
Lead Sponsor:
Humanitas Clinical and Research Center
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
18+ years
Brief Summary
Autologous fat grafting, also known as lipofilling, is a surgical technique consisting in the processing and transfer of adipose tissue from one area in our organism (hips, thighs) to region which in ...
Eligibility Criteria
Inclusion
- female
- breast carcinoma (any histological type, carcinoma in situ included) treated with radical or conservative surgery
- group treated with lipofilling and group which didnt receive lipofilling
- timing: retrospective evaluation of cases form 2006 to 2016, with a minimum of two year follow up
Exclusion
- neoplasie different from infiltrating and in sutu breast carcinoma
- in situ lobular carcinoma
- patients with breast carcinoma and metastasis
- lipofilling procedure used before the oncological treatment for breast carcinoma
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
6510 Patients enrolled
Trial Details
Trial ID
NCT04130373
Start Date
June 1 2019
End Date
June 1 2020
Last Update
October 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinico Humanitas
Rozzano, Milan, Italy, 20089